Drug intelligence / Profile preview

Anluo Huaxian Pills

Development stage: Unknown
Lead developer: Senlong Pharmaceutical
Modality: Small Molecules
Administration: Oral

Overview

Anluo Huaxian Pills (also known as Anluo Chemical Fiber Pills) is a traditional Chinese patent medicine primarily used for the treatment of liver fibrosis. Its main ingredients include turtle shell, tortoise shell, raw rehmannia, and other natural animal and plant-derived substances. The formulation is based on principles of traditional Chinese medicine and is designed to address chronic liver conditions by targeting fibrotic processes in the liver[1][2]. The mechanism of action involves modulation of fibrogenesis pathways; however, specific molecular targets are not well characterized in Western pharmacological terms.

Brand names: Anluo Chemical Fiber Pills
Other names: Anluo Huaxian Pills安络化纤丸

Beyond the preview

Go deeper on Anluo Huaxian Pills.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Anluo Huaxian Pills.

Explore the full profile